Global Search

HIV prevention injections have been registered for use in South Africa. However, their high price and limited supply means that for the next few years, very few people will be able to get the jabs. In this special briefing, Spotlight looks at the difficult choices facing the country if we want to offer the injection to more people more quickly.

Catherine Tomlinson, News24
Populations & Programmes
Long-acting PrEP, CAB-LA, HIV prevention